title: Vaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.
abstract: Concerted efforts of tumor immunologists over more than two decades contributed numerous well-defined tumor antigens, many of which were promptly developed into cancer vaccines and tested in animal models and in clinical trials. Encouraging results from animal models were seldom recapitulated in clinical trials. The impediment to greater success of these vaccines has been their exclusive use for cancer therapy. What clinical trials primarily revealed were the numerous ways in which cancer and/or standard treatments for cancer could suppress the patient's immune system, making it very difficult to elicit effective immunity with therapeutic vaccines. In contrast, there is an extensive database of information from experiments in appropriate animal models showing that prophylactic vaccination is highly effective and safe. There are also studies that show that healthy people have immune responses against antigens expressed on tumors, some generated in response to viral infections and others in response to various nonmalignant acute inflammatory events. These immune responses do not appear to be dangerous and do not cause autoimmunity. Epidemiology studies have shown that these immune responses may reduce cancer risk significantly. Vaccines based on tumor antigens that are expressed differentially between tumors and normal cells and can stimulate immunity, and for which safety and efficacy have been proved in animal models and to the extent possible in therapeutic clinical trials, should be considered prime candidates for prophylactic cancer vaccines.
authors.affiliation: Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania OJFINN@pitt.edu.
authors.forename: Olivera J
authors.initials: OJ
authors.lastname: Finn
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D058872:Epidemics; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D057285:Precision Medicine
chemical_list: D019496:Cancer Vaccines
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5340-2
references.pmid: 10318881
references.citation: FEBS Lett. 2014 Jan 21;588(2):368-76
references.pmid: 24161671
references.citation: Isr J Med Sci. 1973 Mar;9(3):300-7
references.pmid: 4575654
references.citation: Science. 1992 Mar 6;255(5049):1261-3
references.pmid: 1546328
references.citation: Mol Interv. 2010 Aug;10(4):197-203
references.pmid: 20729485
references.citation: Curr Opin Immunol. 1995 Oct;7(5):674-81
references.pmid: 8573311
references.citation: J Exp Med. 2003 Dec 1;198(11):1623-6
references.pmid: 14638849
references.citation: Curr Opin Immunol. 1993 Oct;5(5):701-8
references.pmid: 8240731
references.citation: Cancer Immunol Res. 2014 Mar;2(3):263-73
references.pmid: 24778322
references.citation: Adv Immunol. 1996;62:217-56
references.pmid: 8781270
references.citation: Nature. 2007 Dec 6;450(7171):903-7
references.pmid: 18026089
references.citation: Int J Cancer. 2000 Jun 1;86(5):702-12
references.pmid: 10797294
references.citation: Cancer Treat Res. 2005;123:89-111
references.pmid: 16211867
references.citation: Curr Opin Immunol. 2013 Apr;25(2):192-9
references.pmid: 23465466
references.citation: J Virol. 2006 Jun;80(12):5886-96
references.pmid: 16731927
references.citation: Curr Opin Immunol. 2011 Apr;23(2):265-71
references.pmid: 21277761
references.citation: Cancer Prev Res (Phila). 2013 Jan;6(1):18-26
references.pmid: 23248097
references.citation: Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14010-5
references.pmid: 19666607
references.citation: Eur J Cancer. 2003 Nov;39(16):2372-8
references.pmid: 14556930
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1125-31
references.pmid: 15894662
references.citation: Nature. 2013 May 30;497(7451):544
references.pmid: 23719439
references.citation: Annu Rev Microbiol. 1966;20:223-52
references.pmid: 5330233
references.citation: Cell. 1995 Jul 14;82(1):13-7
references.pmid: 7606778
references.citation: Nat Med. 1998 May;4(5 Suppl):525-31
references.pmid: 9585204
references.citation: J Clin Oncol. 1985 Jun;3(6):876-82
references.pmid: 2409242
references.citation: Johns Hopkins Med J Suppl. 1974;3:37-50
references.pmid: 4608238
references.citation: Curr Opin Immunol. 2013 Apr;25(2):261-7
references.pmid: 23579076
references.citation: Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1155-63
references.pmid: 11700263
references.citation: Am J Obstet Gynecol. 1985 May 1;152(1):116-8
references.pmid: 3993709
references.citation: Nat Mater. 2013 Nov;12(11):978-90
references.pmid: 24150416
references.citation: Proc Natl Acad Sci U S A. 1989 Sep;86(18):7159-63
references.pmid: 2674949
references.citation: J Exp Med. 2010 Sep 27;207(10):2175-86
references.pmid: 20819923
references.citation: Science. 1991 Dec 13;254(5038):1643-7
references.pmid: 1840703
references.citation: Adv Immunol. 2006;90:175-213
references.pmid: 16730264
references.citation: Clin Cancer Res. 2005 Feb 15;11(4):1521-6
references.pmid: 15746055
references.citation: Curr Opin Immunol. 1991 Oct;3(5):646-53
references.pmid: 1684510
references.citation: Annu Rev Immunol. 2007;25:267-96
references.pmid: 17134371
references.citation: Nat Rev Cancer. 2006 Mar;6(3):204-16
references.pmid: 16498443
references.citation: Vaccine. 2012 Jun 19;30(29):4323-7
references.pmid: 22115635
references.citation: Cancer Immunol Immunother. 2011 Feb;60(2):227-34
references.pmid: 20981424
references.citation: N Engl J Med. 2010 Jul 29;363(5):411-22
references.pmid: 20818862
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1595-601
references.pmid: 20501761
references.citation: Curr Opin Immunol. 2004 Apr;16(2):143-50
references.pmid: 15023405
references.citation: J Virol. 2006 Jun;80(11):5577-87
references.pmid: 16699039
references.citation: Cancer Immunol Immunother. 2013 Jul;62(7):1137-48
references.pmid: 23666510
references.citation: Nat Rev Immunol. 2003 Aug;3(8):630-41
references.pmid: 12974478
references.citation: J Natl Cancer Inst. 1990 Dec 19;82(24):1883-9
references.pmid: 2250310
references.citation: Melanoma Res. 1999 Oct;9(5):511-9
references.pmid: 10596918
references.citation: Ann N Y Acad Sci. 2009 Sep;1174:68-73
references.pmid: 19769738